Lode Debrabandere
2011
In 2011, Lode Debrabandere earned a total compensation of $412.5K as President and CEO at Osiris Therapeutics, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Option Awards | $91,500 |
| Salary | $286,000 |
| Total | $412,500 |
Debrabandere received $286K in salary, accounting for 69% of the total pay in 2011.
Debrabandere also received $35K in bonus and $91.5K in option awards.
Rankings
In 2011, Lode Debrabandere's compensation ranked 8,586th out of 10,747 executives tracked by ExecPay. In other words, Debrabandere earned more than 20.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,586 out of 10,747 | 20th |
Division Manufacturing | 3,187 out of 3,960 | 20th |
Major group Chemicals And Allied Products | 796 out of 1,038 | 23rd |
Industry group Drugs | 583 out of 786 | 26th |
Industry Biological Products, Except Diagnostic Substances | 102 out of 162 | 37th |
Source: SEC filing on March 28, 2014.
Debrabandere's colleagues
We found five more compensation records of executives who worked with Lode Debrabandere at Osiris Therapeutics in 2011.
2011
C Mills
Osiris Therapeutics
Chief Executive Officer
2011
Stephen Potter
Osiris Therapeutics
Senior Vice President, of Operations and Corporate Development
2011
Michelle Williams
Osiris Therapeutics
Chief Scientific Officer
2011
Therapeutics Williams
Osiris Therapeutics
Chief Scientific Officer
2011
Philip Jacoby
Osiris Therapeutics